Paper476576
Prognostic value of estrogen receptors in primary breast cancer.
Hähnel R and 2 others. Cancer, 1979. Cited by 254 papers, by iCite.
Cite this record
ConductScience Library. Prognostic value of estrogen receptors in primary breast cancer. Papers, record 476576. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/476576
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Receptors, Estrogen | Major topic |
| Adult | |
| Age Factors | |
| Aged | |
| Female | |
| Humans | |
| Lymphatic Metastasis | |
| Middle Aged | |
| Prognosis | |
| Recurrence | |
| Remission, Spontaneous | |
| Time Factors |
Source PubMed
Cited by64
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 254 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41326583 | Identification and in silico evaluation of natural compounds from Annona muricata (soursop) leaves for colon cancer treatment. | Sci Rep | 2025 | https://conductscience.org/library/papers/41326583 | PubMed |
| 36268080 | Integrating and validating automated digital imaging analysis of estrogen receptor immunohistochemistry in a fully digital workflow for clinical use. | J Pathol Inform | 2022 | https://conductscience.org/library/papers/36268080 | PubMed |
| 35626173 | Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature). | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35626173 | PubMed |
| 34725978 | Safety and Effectiveness of F-18 Fluoroestradiol Positron Emission Tomography/Computed Tomography: a Systematic Review and Meta-analysis. | J Korean Med Sci | 2021 | https://conductscience.org/library/papers/34725978 | PubMed |
| 33734106 | Quantitative Image Analysis for Tissue Biomarker Use: A White Paper From the Digital Pathology Association. | Appl Immunohistochem Mol Morphol | 2021 | https://conductscience.org/library/papers/33734106 | PubMed |
| 33597950 | A Phenomic Perspective on Factors Influencing Breast Cancer Treatment: Integrating Aging and Lifestyle in Blood and Tissue Biomarker Profiling. | Front Immunol | 2020 | https://conductscience.org/library/papers/33597950 | PubMed |
| 29285040 | Tamoxifen and the Risk of Parkinson's Disease in Female Patients with Breast Cancer in Asian People: A Nationwide Population-Based Study. | J Breast Cancer | 2017 | https://conductscience.org/library/papers/29285040 | PubMed |
| 29271260 | Protein biomarkers for subtyping breast cancer and implications for future research. | Expert Rev Proteomics | 2018 | https://conductscience.org/library/papers/29271260 | PubMed |
| 26659386 | Quantification of Estrogen Receptor-Alpha Expression in Human Breast Carcinomas With a Miniaturized, Low-Cost Digital Microscope: A Comparison with a High-End Whole Slide-Scanner. | PLoS One | 2015 | https://conductscience.org/library/papers/26659386 | PubMed |
| 25478233 | Prevalence of HER-2 and Hormone Receptors and P53 Mutations in the Pathologic Specimens of Breast Cancer Patients. | Int J Breast Cancer | 2014 | https://conductscience.org/library/papers/25478233 | PubMed |
| 22820659 | Quantitative analysis of estrogen receptor expression shows SP1 antibody is more sensitive than 1D5. | Appl Immunohistochem Mol Morphol | 2013 | https://conductscience.org/library/papers/22820659 | PubMed |
| 20567632 | Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance. | Clin Med Insights Oncol | 2010 | https://conductscience.org/library/papers/20567632 | PubMed |
| 16696013 | Biological indices in the assessment of breast cancer. | Clin Mol Pathol | 1995 | https://conductscience.org/library/papers/16696013 | PubMed |
| 16628414 | Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer. | Virchows Arch | 2006 | https://conductscience.org/library/papers/16628414 | PubMed |
| 15084231 | Prognostic molecular markers in early breast cancer. | Breast Cancer Res | 2004 | https://conductscience.org/library/papers/15084231 | PubMed |
| 10929927 | Is there a growing role for endocrine therapy in the treatment of breast cancer? | Drugs | 2000 | https://conductscience.org/library/papers/10929927 | PubMed |
| 10146895 | Systemic therapy in breast cancer: efficacy and cost utility. | Pharmacoeconomics | 1994 | https://conductscience.org/library/papers/10146895 | PubMed |
| 8982381 | Expression of the PIP/GCDFP-15 gene and survival in breast cancer. | Virchows Arch | 1996 | https://conductscience.org/library/papers/8982381 | PubMed |
| 8554983 | Oestrogen receptor: a stable phenotype in breast cancer. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8554983 | PubMed |
| 8435475 | Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. | Breast Cancer Res Treat | 1993 | https://conductscience.org/library/papers/8435475 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/476576
GET https://conductscience.org/api/papers/v1/476576/cited_by?page=2